Dashboard
Analysis
Charting
Screener
Resources
Settings
NYSE-NET
Dec '16
Dec '18
Mar '20
Jun '21
Sep '22
Dec '23
Mar '25
Trailing Valuation
Stock Price
214.6
195.8
112.7
107.7
80.9
82.8
Total Shares Outstanding
350.2
348.4
346.5
344.9
343
341.5
Market Cap
75,149.8
68,230.1
39,050.4
37,134
27,749.1
28,289.5
Total Enterprise Value (TEV)
74,608.1
67,732.5
38,611.4
36,741.3
27,376
27,970.7
Buyback Yield
0%
-0%
Debt Paydown Yield
—
Shareholder Yield
P/S
37.3
36.3
22.1
22.2
17.7
19.1
P/Gross Profit
49.6
47.6
28.7
28.8
22.8
24.8
P/E
-715.3
-576
-490
-468.2
-311.1
-285.6
Earnings Yield
-0.1%
-0.2%
-0.3%
-0.4%
P/OCF
139.2
142.3
86.3
97.6
81.5
94.3
P/FCF
317.9
324.2
182.7
190
140.2
157
FCF Yield
0.3%
0.5%
0.7%
0.6%
P/B
55.8
55
27.4
35.5
28.5
32.1
EV/Sales
37.1
36
21.8
22
17.4
18.9
EV/Gross Profit
49.3
47.3
28.4
22.5
24.5
EV/EBITDA
919.4
1,093.9
527.7
671.2
650.7
860.8
EV/EBIT
-387.2
-364.1
-251.6
-237.4
-168.1
-163.3
EV/OCF
138.2
141.2
85.3
96.6
80.4
93.3
EV/FCF
315.6
321.8
180.6
188
138.4
155.3
Margins
Gross Profit Margin
74%
74.9%
75.9%
76.4%
77.7%
77.8%
Operating Margin
-6.7%
-13.1%
-11.1%
-7.5%
-7.2%
-8.7%
EBITDA Margin
7.3%
2.7%
5.1%
5%
3.7%
Net Profit Margin
-9.8%
-8%
-2.8%
-3.6%
-3.8%
Effective Tax Rate
169.7%
-4.6%
-18.5%
-19.6%
-8.2%
Pre-Tax Profit Margin
-9.2%
-7.7%
-2.4%
-3%
-3.5%
Free Cash Flow Margin
14.7%
7.8%
12.5%
11.8%
13.1%
10.8%
OCF / Sales
29.7%
19.5%
30.4%
27.7%
24.8%
18.2%
OCF / Net Income
-12,955.3%
-197.8%
-379.1%
-990.9%
-696.2%
-482.9%
FCF / OCF
49.4%
40%
41.1%
42.5%
53%
59.3%
FCF / Net Income
-6,394.7%
-79.1%
-155.8%
-421.5%
-368.7%
-286.4%
FCF / EBITDA
201.9%
1,114.2%
457.8%
229.2%
261.4%
291.3%
Capital Efficiency
Return on Invested Capital
1.2%
-4.8%
-3.9%
-3.1%
-3.3%
Return on Assets
-1.7%
-1.4%
-1.3%
Return on Equity
-1.8%
-2%
Return on Total Capital
1.1%
-2.9%
-2.6%
Return on Capital Employed
-1.9%
-2.1%
-1.5%
-1.6%
Return on Tangible Assets
-1.2%
-0.5%
-0.6%
Receivables Turnover
1.8
1.7
1.6
Days Sales Outstanding
208.1
210.9
200.8
235.1
202.6
204.7
Payables Turnover
1.4
1.9
Days Payables Outstanding
199.6
220.1
223.6
267.9
218.1
188.4
Cash Conversion Cycle
8.6
-9.3
-22.8
-32.7
-15.5
16.2
Asset Turnover
0.1
0.2
Fixed Asset Turnover
0.8
0.9
Operating Cycle
CapEx to OCF
0.5
0.6
0.4
CapEx to Revenue
CapEx to Depreciation
1.1
1.3
1
Financial Health
Total Debt
3,501.8
3,462.1
1,475.9
1,463.2
1,450.7
1,438.6
Net Debt
-541.8
-497.6
-439
-392.7
-373.1
-318.8
Current Ratio
2
5.1
3.2
2.9
3.4
3.5
Quick Ratio
5
2.7
2.8
3.3
Cash Ratio
4.6
2.3
Debt Ratio
Assets to Equity
4.3
4.5
2.6
3.1
Cash Flow to Debt Ratio
0
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
97.4
83.2
328.9
14
74.2
57.9
Goodwill / Assets
Debt / Equity
1.5
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
-13.3
-139
-33.6
-16.6
-17.3
-21.5
EBIT / Interest Expense
-12.9
-44.1
-36.9
-24
-28.5
EBITDA / Interest Expense
9.1
16.4
15.1
12.2
(EBITDA - Capex) / Interest Expense
-15
-37
-50.5
-34.3
-19.9
-12.1
Per Share
Revenue per Share
1.2
Basic EPS
-0.2
-0.1
-0
Diluted EPS
Book Value per Share
3.9
3.6
4.1
3
Tangible Book Value per Share
2.5
2.1
Cash per Share
11.6
11.4
5.5
5.4
5.3
5.2
Operating Cash Flow per Share
0.3
Free Cash Flow per Share
CapEx per Share
Weighted Avg. Shares Outstanding
349.3
347.5
345.7
344
342.4
340.6
Weighted Avg. Shares Outstanding Diluted
Common Size
R&D to Revenue
21.5%
26.3%
24%
26.1%
25.8%
25.6%
SG&A to Revenue
59.1%
61.7%
63%
57.8%
60.9%
Stock-based Comp to Revenue
19.6%
23.9%
19.9%
20.7%
20.3%
21.4%
